Abstract
It has been more than 100 years since the suggestion was made that the control of cancer was mediated by immunologic methods. This hypothesis was based on the observation that tumors either partially or totally regressed in a few patients following an acute bacterial infection. In 1911, William Coley pioneered the study of mixed bacterial vaccines or their product known as “Coley’s toxin,” for treating cancers, and there is no doubt that these vaccines had some effect in many cases (Nauts et al., 1946). The effective ingredient appeared to be endotoxin, which caused hemorrhagic necrosis of the tumors. Thus, Gratia and Linz discovered in guinea pigs (1931) and Shwartzman and Michailovsky in mice (1932) that when animals with solid tumors are given single i.v. or i.p. inoculations with small doses of endotoxin, their tumors became hemorrhagic within 24 hr. This was originally done by analogy with the local Shwartzman reaction, with the idea that some hypothetical tumor virus might have prepared the site. It appeared that this type of tumor damage was mediated indirectly because little of the injected endotoxin would be likely to make contact with tumor cells, and would not exert any direct cytotoxicity in any case (Shapiro, 1940; Brailovsky et al., 1973).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Adam, A., Cirobaru, R., Ellouz, F., Petit, J.-F., and Lederer, E., 1974, Adjuvant activity of monomeric bacterial cell wall peptidoglycans, Biochem. Biophys. Res. Commun. 56:561.
Alexander, P., 1977, Back to the drawing board—The need for more realistic model systems for immunotherapy, Cancer 40:467.
Alexander, P., and Evans, R., 1971, Endotoxin and double-stranded RNA render macrophages cytotoxic, Nature New Biol. 232:76.
Amano, K., Ribi, E., and Cantrell, J. L., 1982, Different structural requirements of endotoxic glycolipid for tumor regression and endotoxic activity, Biochem. Biophys. Res. Comm. 106:667.
Anacker, R. L., Barclay, W. R., Brehmer, W., Larson, C. L., and Ribi, E., 1967, Duration of immunity to tuberculosis in mice vaccinated intravenously with oil-treated cell walls of Mycobacterium bovis strain BCG, J. Immunol. 98:1265.
Azuma, I., Ribi, E., Meyer, T. J., and Zbar, B., 1974, Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and P3, J. Natl. Cancer Inst. 52:95.
Barclay, W. R., Anacker, R. L., Brehmer, W., and Ribi, E., 1967, Effects of oil-treated mycobacterial cell walls on the organs of mice, J. Bacteriol 94:1736.
Berendt, M. J., North, R. J., and Kirsten, D. P., 1978, The immunological basis of endo-toxin-induced tumor regression: Requirement for T-cell-mediated immunity, J. Exp. Med. 148:1550.
Brailovsky, C., Trudel, M., Lallier, R., and Nigam, V. N., 1973, Growth of normal and transformed rat embryo fibroblasts: Effects of glycolipids from Salmonella minnesota R mutants, J. Cell Biol. 57:124.
Braun, V., Rehn, K., and Wolff, H., 1970, Supramolecular structure of the rigid layer of the cell wall of Salmonella, Serratia, Proteus, and Pseudomonas fluorescens: Number of lipoprotein molecules in a membrane layer, Biochemistry 9:5041.
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., and Williamson, B., 1975, An endotoxin-induced serum factor that causes necrosis of tumors, Proc. Natl. Acad. Sci. USA 72:3666.
Chapman, H. A., Jr., and Hibbs, J. B., Jr., 1977, Modulation of macrophage tumoricidal capability by components of normal serum: A central role for lipid, Science 197:282.
Ellouz, F., Adam, A., Ciorbaru, R., and Lederer, E., 1974, Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives, Biochem. Biophys. Res. Commun. 59:1317.
Galanos, C., Lüderitz, O., and Westphal, O., 1969, A new method for the extraction of R lipopolysaccharides, Eur. J., Biochem. 9:245.
Granger, D. L., Yamamato, K., and Ribi, E., 1976, Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets,J. Immunol. 116:482.
Gratia, A., and Linz, R., 1931, Le phénomène de Shwartzman dans la sarcome du cobaye, C. R. Soc. Biol. 108:427.
Haskins, W. T., Landry, M., Milner, K. C., and Ribi, E., 1961, Biological properties of parent endotoxins and lipoid fractions, with a kinetic study of acid-hydrolyzed endotoxin, JExp. Med. 114:665.
Hausman, M. S., Snyderman, R., and Mergenhagen, S. E., 1972, Humoral mediators of Chemotaxis of mononuclear leukocytes, JInfect. Dis. 125:595.
Hibbs, J. B., Jr., Taintor, R. R., Chapman, H. A., Jr., and Weinberg, J. B., 1977, Macrophage tumor killing: Influence of the local environment, Science 197:279.
Hoffmann, M. K., Green, S., Old, L. J., and Oettgen, H. F., 1976, Serum containing en-dotoxin-induced tumour necrosis factor substitutes for helper T cells, Nature (London) 263:416.
Johnson, A. G., and Nowotny, A., 1964, Relationship of structure to function in bacterial O antigens. III. Biological properties of endotoxins, JBacteriol. 87:809.
Joiner, K. A., and Wolff, S. M., 1981, The role of endotoxin in human disease and its therapy, in: Augmenting Agents in Cancer Therapy (Hersh, E. M, Chirigos, M. A., and M. J. Mastrangclo, eds.), pp. 125–134, Raven Press, New York.
Kelly, M. T., McLaughlin, C. A., and Ribi, E., 1978, Eradication of microscopic lymph node metastases of the guinea pig line 10 tumor after intralesional injection of endotoxin plus mycobacterial components, Cancer Immunol. Immunother. 4:29.
Kleinschuster, S. J., Rapp, H. J., Leukcr, D. C., and Kainer, R. A., 1977, Regression of bovine ocular carcinoma by treatment with a mycobacterial vaccine, J. Satl. Cancer Inst. 58:1807.
Kotani, S., Watanabe, Y., Kinoshita, F., Shimono, T., Morisaki, T., Shiba, T., Kusumoto, S., Tarumi, Y., and Ikenaka, K., 1975, Immunoadjuvant activities of synthetic S-acetylmuramylpeptides or amino acids, Biken J. 18:105.
Lüderitz, O., Galanos, C., Lehmann, V., Norminen, M., Rietschel, E. T., Rosenfelder, G., Simon, M., and Westphal, O., 1973, Lipid A: Chemical structure and biological activity, JInfect. Dis. 128(Suppl.):17.
Lüderitz, O., Galanos, C., Lehmann, V., Mayer, H., Rietschel, E. T., and Weckesser, J., 1978, Chemical structure and biological activities of lipid A’s from various bacterial families, Saturwissenschaften 65:578.
Mclntire, F. C., Hargie, M. P., Schenck, J. R., Finley, R. A., Sievert, H. W., Rietschel, E. T., and Rosenstreich, D. L., 1976, Biologic properties of nontoxic derivatives of lipo-polysaccharide from Escherichia coli K235, J. Immunol. 117:674.
McLaughlin, C. A., Bickel, W. D., Kyle, J. S., and Ribi, E., 1978, Synergistic tumor-regressive activity observed following treatment of line-10 heptocellular carcinomas with deproteinized BCG cell walls and mutant Salmonella typhimunum glycolipid, Cancer Immunol. Immunother. 5:45.
Merser, C., Sinay, P., and Adam, A., 1975, Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives, Bwchem. Biophys. Res. Commun. 66:1316.
Meyer, R. J., Ribi, E., Azuma, I., and Zbar, B., 1974, Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma, J. Natl. Cancer Inst. 52:103.
Milner, K. C., and Finkelstein, R. A., 1966, Bioassay of endotoxin: Correlation between pyrogenicity for rabbits and lethality for chick embryos, JInfect. Dis. 116:529.
Milner, K. C., Rudbach, J. A., and Ribi, E., 1971, Bacterial endotoxins: General characteristics, in: Microbial Toxins: A Comprehensive Treatise (G. Weinbaum, S. Kadis, and S. J. Ajl, eds.), pp. 1–65, Academic Press, New York.
Nakae, T., 1976, Identification of the outer membrane proteins of E. coli that produce transmembrane channels in reconstituted vesicle membranes, Biochem. Biophys. Res. Commun. 71:877.
Nauts, H. C., Swift, W. E., and Coley, B. L., 1946, The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M. D., reviewed in the light of modern research, Cancer Res. 6:205.
Nowotny, A., 1963a, Endotoxoid preparations, Nature (London) 197:721.
Nowotny, A., 1963b, Relation of structure to function in bacterial O-antigens. II. Fractionation of lipids present in Boivin-type endotoxin of Serratia marcescens, J. Bactenol. 85:427.
Okuyama, H., Onoc, K., Takeda, J., and Morikawa, K., 1976, Histological studies on the adjuvanticity of BCG-cell wall, Recent Adv. RES Res. 16:67.
Perrault, A., and Shear, M. J., 1949, Ehe bacterial cell of 5. marcescens as a source of tu-mor-necrotising polysaccharide, Cancer Res. 9:626.
Rapp, H. J., 1973, A guinea pig model for tumor immunology: A summary, Isr. J. Med. Sci. 9:366.
Ribi, E., Milner, K. C., and Perrine, T. D., 1959, Endotoxic and antigenic fractions from the cell wall of Salmonella ententidis: Methods for separation and some biologic activities, J. Immunol. 82:75.
Ribi, E., Haskins, W. T., Eandy, M., and Milner, K. C., 1961, Preparation and host-reactive properties of endotoxin with low content of nitrogen and lipid, JExp. Med. 114: 647.
Ribi, E., Anacker, R. L., Brown, R., Haskins, W. T., Malmgren, B., Milner, K. C., and Rudbach, J. A., 1966a, Reaction of endotoxin and surfactants. I. Physical and biological properties of endotoxin treated with sodium deoxycholate, J. Bactenol. 92:1493.
Ribi, E., Larson, C., Wicht, W., List, R., and Goode, G., 1966b, Effective nonliving vaccine against experimental tuberculosis in mice, J. Bactenol. 91:975.
Ribi, E., Anacker, R. L., Barclay, W. R., Brehmer, W., Harris, S. C., Leif, W. R., and Simmons, J., 1971, Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the rhesus monkey, JInfect. Dis. 123:527.
Ribi, E., Parker, R., and Milner, K. C., 1974, Microparticulate gel chromatography accelerated by centrifugal force and pressure, Methods Biochem. Anal. 22:355.
Ribi, E., Granger, D. L., Milner, K. C., and Strain, S. M., 1975, Brief communication: Tumor regression caused by endotoxins and mycobacterial fractions, J. Natl. Cancer Inst. 55:1253.
Ribi, E., Milner, K. C., Granger, D. L., Kelly, M. T., Yamamoto, K., Brehmer, W., Parker, R., Smith, R. F., and Strain, S. M., 1976a, Immunotherapy with nonviable microbial components, Ann. NY. Acad. Sci. 277:228.
Ribi, E., Milner, K. C., Kelly, M. T., Granger, D. L., Yamamoto, K., McLaughlin, C. A., Brehmer, W., Strain, S. M., Smith, R. F., and Parker, R., 1976b, Structural requirements of microbial agents for immunotherapy of the guinea pig line-10 tumor, in: BCC in Cancer Immunotherapy (G. Lamoureux, R. Turcotte, and V. Portelance, eds.), pp. 51–61, Grüne Sc Stratton, New York.
Ribi, E., McLaughlin, G. A., Gantrell, J. L., Brehmer, W., Azuma, I., Yamamura, Y., Strain, S. M., Hwang, K. M., and Toubiana, R., 1978, Immunotherapy for tumors with microbial constituents or their synthetic analogues: A review, in: Immunotherapy of Human Cancer, pp. 131–154, Raven Press, New York.
Ribi, E., Parker, R., Strain, S. M., Mizuno, Y., Nowotny, A., Von Eschen, K. B., Cantrell, J. L., McLaughlin, G. A., Hwang, K. M., and Goren, M. B., 1979a, Peptides as requirement for immunotherapy of the guinea pig line-10 tumor with endotoxins, Cancer Immunol. Immunother. 7:43.
Ribi, E., Gantrell, J. L., Von Eschen, K., and Schwartzman, S., 1979b, Enhancement of endotoxic shock by adjuvant dipeptide (MDP), Cancer Res. 39:4756.
Ribi, E., Gantrell, J. L., Schwartzman, S. M., and Parker, R., 1981, BCG cell wall skeleton, P3, MDP and other microbial components — Structure activity studies in animals models, in: Augmenting Agents in Cancer Therapy (E. M. Hersh, M. A. Chirigos, and M.J. Mastrangelo, eds.), pp. 15–31, Raven Press, New York.
Ribi, E., Amano, K., Gantrell, J., Schwartzman, S., Parker, R., and Takayama, K., 1982, Preparation and anti-tumor activity of nontoxic lipid A, Cancer Immunol. Immunother. 12:91.
Richman, S. P., Gutterman, J. U., Hersh, E. M., and Ribi, E., 1978, Phase I-II study of intratumor immunotherapy with BCG cell wall skeleton plus P3, Cancer Immunol. Immunother. 5:41.
Rosner, M. R., Tang, J. Y., Barzilay, I., and Khorana, H. G., 1979, Structure of the lipo-polysaccharide from Escherichia coli heptoseless mutant, J. Biol. Chem. 254:5906.
Schenck, J. R., Hargie, M. P., Brown, M. S., Ebert, D. S., Yoo, A. L., and Mclntire, F. C., 1969, The enhancement of antibody formation by Escherichia coli lipopolysaccharide and detoxified derivatives, J. Immunol. 102:1411.
Shapiro, C. J., 1940, The effect of a toxic carbohydrate complex from S. enteritidis on transplantable rat tumors in tissue culture, Am. J. Hyg. 31(Sect. B):114.
Shwartzman, G., and Michailovsky, N., 1932, Phenomenon of local skin reactivity to bacterial filtrates in the treatment of mouse sarcoma 180, Proc. Soc. Exp. Biol, Med. 29: 737.
Takayama, K., Ribi, E., and Cantrell, J. L., 1981, Isolation of a nontoxic lipid A fraction containing tumor regression activity, Cancer Res. 41:2654.
Vosika, G. J., Schmidtke, J. R., Goldman, A., Ribi, E., Parker, R., and Gray, G. R., 1979a, Intralesional immunotherapy of malignant melanoma with Mycobacterium smegmatis cell wall skeleton combined with trehalose dimycolate, Cancer 44:495.
Vosika, G. J., Schmidtke, J. R., Goldman, A., Parker, R., Ribi, E., and Gray, G. R., 1979b, Phase I–II study of intralesional immunotherapy with oil attached Mycobacterium smegmatis cell wall skeleton and trehalose dimycolate, Cancer Immunol. Immunother. 6:135.
Westphal, O., and Lüderitz, O., 1954, Chemische Erforschung von Lipopolysacchariden gram negativer Bakterien, Angew. Chem. 66:407.
Zbar, B., Bernstein, I. D., and Rapp, H. J., 1971, Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin, J. Natl. Cancer Inst. 46:831.
Zbar, B., Ribi, E., and Rapp, H. J., 1973, An experimental model for immunotherapy of cancer, Natl. Cancer Inst. Monogr. 39:3.
Zbar, B., Ribi, E., Kelly, M., Granger, D., Evans, C., and Rapp, H. J., 1976, Immunologic approaches to the treatment of human cancer based on a guinea pig model, Cancer Immunol. Immunother. 1:127.
Zbar, B., Canti, G., Ashley, M. P., Rapp, H. J., Hunter, J. T., and Ribi, E., 1979, Eradication by immunization with mycobacterial vaccines and tumor cells of microscopic metastases remaining after surgery, Cancer Res. 39:1597.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Ribi, E., Cantrell, J.L., Takayama, K., Amano, Ki. (1983). Enhancement of Antitumor Resistance by Mycobacterial Products and Endotoxin. In: Nowotny, A. (eds) Beneficial Effects of Endotoxins. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4364-6_27
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4364-6_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4366-0
Online ISBN: 978-1-4684-4364-6
eBook Packages: Springer Book Archive